Search Results | MSF Science Portal

Journal Article

|

Letter

Schomaker M, Kerschberger B, Boulle AM

2023-08-05 • Clinical Infectious Diseases

Journal Article

|

Research

Patten GE, Euvrard J, Anderegg N, Boulle AM, Arendse KD, et al.

2022-11-24 • AIDS

OBJECTIVE
Despite improved access to antiretroviral therapy (ART) for people with HIV (PWH), HIV continues to contribute considerably to morbidity and mortality. Increasingly, advanc...

Journal Article

|

Research

Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Trivino Duran L, et al.

2022-07-31 • AIDS and Behavior

Men have higher rates of attrition from antiretroviral therapy (ART) programs than women. In Khayelitsha, a high HIV prevalence area in South Africa, two public sector primary healthcare...

Journal Article

|

Letter

Patten GE, Cox V, Stinson K, Boulle AM, Wilkinson LS

2014-04-23 • Clinical Infectious Diseases

Journal Article

|

Review

Stinson K, Goemaere E, Coetzee D, van Cutsem G, Hilderbrand K, et al.

2016-05-20 • International Journal of Epidemiology

Journal Article

|

Research

Fenner L, Atkinson A, Boulle AM, Fox MP, Prozesky HW, et al.

2017-06-23 • Journal of the International AIDS Society

Chronic immune activation due to ongoing HIV replication may lead to impaired immune responses against opportunistic infections such as tuberculosis (TB). We studied the role of HIV repl...

Journal Article

|

Research

Estill J, Egger M, Johnson LF, Gsponer T, Wandeler G, et al.

2013-02-28 • PLOS One

OBJECTIVES
Mortality in patients starting antiretroviral therapy (ART) is higher in Malawi and Zambia than in South Africa. We examined whether different monitoring of ART (viral loa...

Journal Article

|

Research

Hwang B, Shroufi A, Gils T, Steele SJ, Grimsrud A, et al.

2019-03-12 • PLOS One

BACKGROUND
HIV and TB programs have rapidly scaled-up over the past decade in Sub-Saharan Africa and uninterrupted supplies of those medicines are critical to their success. However,...

Protocol

|

Research Protocol

Fernandez MAL, Schomaker M, Mason PR, Fesselet JF, Baudot Y, et al.

2012-06-18

BACKGROUND
In highly populated African urban areas where access to clean water is a challenge, water source contamination is one of the most cited risk factors in a cholera epidemic....

Journal Article

|

Research

Rice B, Boulle AM, Schwarcz S, Shroufi A, Rutherford G, et al.

2019-03-20 • JMIR Public Health Surveill

The move toward universal provision of antiretroviral therapy and the expansion of HIV viral load monitoring call into question the ongoing value of CD4 cell count testing and monitoring...

Journal Article

|

Research

Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al.

2010-09-10 • AIDS

OBJECTIVE: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, ...

Journal Article

|

Research

Cornell M, Technau KG, Fairall L, Wood R, Moultrie H, et al.

2009-09-01 • South African Medical Journal

OBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South...

Journal Article

|

Research

Chu KM, Boulle AM, Ford NP, Goemaere E, Asselman V, et al.

2010-02-17 • PLOS One

BACKGROUND: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen contain...

Journal Article

|

Research

Ballif M, Zurcher K, Reid SE, Boulle AM, Fox MP, et al.

2018-01-11 • BMJ Open

Seasonal variations in tuberculosis diagnoses have been attributed to seasonal climatic changes and indoor crowding during colder winter months. We investigated trends in pulmonary tuber...

Journal Article

|

Research

Lawn SD, Campbell L, Kaplan R, Boulle AM, Cornell M, et al.

2011-06-01 • Journal of Acquired Immune Deficiency Syndromes (1999)

We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per micro...

Journal Article

|

Research

Rangaka MX, Wilkinson RJ, Boulle AM, Glynn JR, Fielding K, et al.

2014-05-14 • Lancet

Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...

Journal Article

|

Research

Cox HS, Hughes J, Daniels J, Azevedo VD, McDermid C, et al.

2014-04-01 • International Journal of Tuberculosis and Lung Disease

SETTING: Khayelitsha, South Africa, a peri-urban township with high burdens of tuberculosis (TB), drug-resistant tuberculosis (DR-TB), and human immunodeficiency virus (HIV) infection.

Journal Article

|

Research

Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C, et al.

2022-01-25 • Journal of the International AIDS Society

INTRODUCTION
Youth living with HIV (YLWH) are less likely to initiate antiretroviral therapy (ART) and remain in care than older adults. It is important to identify effective strate...

Journal Article

|

Research

Boulle AM, Schomaker M, May MT, Hogg RS, Shepherd B, et al.

2014-09-09 • PLOS Medicine

BACKGROUND
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-t...

Journal Article

|

Letter

Stinson K, Ford NP, Cox V, Boulle AM

2014-02-05 • Clinical Infectious Diseases

Science Portal

Response to “treatment outcomes after offering same-day Initiation of human immunodeficiency virus (HIV) treatment—how to interpret discrepancies between different studies”

Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model

Attrition from care among men initiating ART in male-only clinics compared with men in general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007-2012 in Khayelitsha, South Africa

Cohort profile: the Khayelitsha antiretroviral programme, Cape Town, South Africa

HIV Viral Load as an Independent Risk Factor for Tuberculosis in South Africa: Collaborative Analysis of Cohort Studies

Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study

Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey

Elevation and cholera: an epidemiological spatial analysis of the cholera epidemic in Harare, Zimbabwe, 2008-2009

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration

Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes

Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

Attrition from HIV care among youth initiating ART in youth-only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

Patients lost to care are more likely to be viremic than patients still in care